Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Innovative Pharmaceutical Biotech ( (HK:0399) ) is now available.
Starcoin Group Limited has entered into two Memorandums of Understanding (MOUs) with Supernova and Scaling Lab, respectively. The first MOU with Supernova aims to establish a collaboration framework for developing blockchain systems and managing token issuance, while also representing Supernova in projects related to AQP Functional Water Technology. The second MOU with Scaling Lab focuses on conducting scientific research on cardiovascular disease and water channel proteins. These initiatives could potentially enhance Starcoin’s position in both the biotechnology and blockchain industries, although they remain subject to formal agreements.
More about Innovative Pharmaceutical Biotech
Innovative Pharmaceutical Biotech, now known as Starcoin Group Limited, operates in the biotechnology and blockchain sectors. The company focuses on developing blockchain-based systems and related token issuance, as well as engaging in institutional cooperation projects involving biotechnologies.
Average Trading Volume: 23,291,680
Technical Sentiment Signal: Buy
Current Market Cap: HK$707.1M
For an in-depth examination of 0399 stock, go to TipRanks’ Overview page.